← Leaderboards
Eileen Anne Friedman
Upstate Medical University
$2,262,573
Attributed
$2,262,573
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $279.9K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,262,573 · 3
By mechanism
R01$1,888,526 · 2
R21$374,047 · 1
Top collaborators
No co-investigators on record.
Most similar at Upstate Medical University
Same institution · by research overlap
- Ying Huang$2,446,524
- David M Gilbert$17,367,305
- David C Amberg$3,825,974
- M Saeed Sheikh$3,525,227
Others in their field
Top investigators on “Enzyme Activity”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$47,808,754
- Susan Abushakra · Alzheon, Inc.$47,265,244
- David Heimbrook · Leidos Biomedical Research, Inc.$45,964,082
- Stuart L Schreiber · Harvard University (Medical School)$40,631,496
- Keith O Hodgson · Stanford University$37,935,767
Research focus
Enzyme ActivityColon NeoplasmsHuman TissueAntisense Nucleic AcidProtein KinaseMonoclonal AntibodyLung NeoplasmsOligonucleotidesStriated MusclesYeast Two Hybrid SystemImmunocytochemistryComplementary DnaInsulinlike Growth FactorCohortClinically RelevantCancer CellCessation Of LifeCell SurvivalBiological FactorsAntioxidantsDyesDuctal Epithelial CellEmbryoCells
Grant awards (9)
A Novel ROS Controlling Kinase$167,857
R21 · FY2011 · CA · contact PI
A Novel ROS Controlling Kinase$206,190
R21 · FY2010 · CA · contact PI
Mirk Kinase in Colon Cancer Development$279,879
R01 · FY2005 · CA
Mirk Kinase in Colon Cancer Development$279,879
R01 · FY2004 · CA
Mirk Kinase in Colon Cancer Development$279,879
R01 · FY2003 · CA
Mirk Kinase in Colon Cancer Development$279,879
R01 · FY2002 · CA
Mirk Kinase in Colon Cancer Development$279,879
R01 · FY2001 · CA
TGFBETA1 IN COLON CANCER PROGRESSION$247,376
R01 · FY2001 · CA
TGFBETA1 IN COLON CANCER PROGRESSION$241,755
R01 · FY2000 · CA